590 research outputs found

    CLINICAL STUDIES OF THE VACCINE PREPARATION FOR PREVENTION OF FLEXNER DYSENTERY ON THE BASIS OF MODIFIED SHIGELLA FLEXNERI LIPOPOLYSACCHARIDE (BASED ON THE RESULTS OF THE I PHASE OF CLINICAL TRIALS)

    Get PDF
    The article presents the results of the I phase of clinical trials of a vaccine preparationfor prevention of Flexner dysentery on the basis of modified Shigella flexneri lipopolysaccharide on the limited contingent of adult volunteers (26 persons). Studying general and local post-inoculative reactions showed good acceptability and low reactogenicity of candidate vaccine "FLEXVAC®" in the doses from 25 to 100 gg. In the majority ofvolunteers immunized by the candidate vaccine "FLEXVAC®" we registered 4 and more times seroconversion of IgG and IgA classes antibodies playing basic role in the formation of adaptive anti-shigella immune response

    IMMUNOLOGICAL CHARACTERISTIC OF SYNTHETIC PEPTIDES SIMILAR TO ACTUAL HIV ANTIGEN DETERMINANTS

    Get PDF
    The development of HIV vaccine remains an important goal in prophylaxis and therapy of HIV/ AIDS epidemics. There are various approaches for development of а candidate vaccine based on induction of neutralizing antibodies and cell-mediated immunity. Synthetic peptides are considered promising vaccine antigens since they are capable of activating both humoral and cellular immune response. HIV-1 envelope gp120 is the target for neutralizing antiviral antibodies. The V3 region of the HIV-1 gp120 is highly immunogenic and important for the virus-coreceptor interaction. In a RV144 vaccine trial, the levels of vaccine-induced IgG antibodies recognizing V1V2 regions from multiple HIV-1 subtypes show inverse correlations with a risk for HIV-1 infection. Meanwhile, HIV is characterized by high diversity. The consensus and mosaic immunogens are complete but artificial proteins, which are computationally designed to elicit immune responses with improved cross-reactive broadness. We have been studied immunogenic properties of synthetic peptides derived from V1, V2, V3 loop regions of the consensus M HIV1 (CON-S) sequence group of the gp 120 envelope protein and V3 loop derived from a Russian RUA022a2 isolate. These peptides specifically reacted to HIV-positive sera in ELISA, thus indicating their similarity to appropriate HIV proteins. The peptides proved to be weakly immunogenic. Therefore, Freund complete adjuvant was used to enhance peptide immunogenicity. To assess the immunogenicity, the mice were immunized with a peptide mixture. Antibodies have been developed to every peptide from the mixture, being, predominantly, of IgG isotype. The antibody titers depended on the length of peptide sequences. However, the sera from immunized mice did not have a HIV neutralizing activity. The serum neutralization was assessed by pseudovirus-based assay, using a molecular clone of virus isolates CAP 45.2.00.G3 and QH.209.14.M.EnvA2. The virus neutralization is a complex process and may be influenced by several factors, such as antibody titer, isotype, or antibody structure. Probably, to induce neutralizing antibodies by this peptide mixture, it is necessary to choose appropriate adjutants and immunization schedule. Moreover, it was shown that peptides could increase in vitro virus infectivity in pseudovirus-based model, using the CAP 45.2.00.G3, QH209.14M.ENV.A2, QD435.100M.ENV.E1 molecular clone. These viral isolates belong to different HIV-1 subtypes

    Elliptic Flow of Electrons from Heavy-Flavor Hadron Decays in Au + Au Collisions at √\u3cem\u3e\u3csup\u3es\u3c/sup\u3e\u3csub\u3eNN\u3c/sub\u3e\u3c/em\u3e = 200, 62.4, and 39 GeV

    Get PDF
    We present measurements of elliptic flow (ν2) of electrons from the decays of heavy-flavor hadrons (eHF) by the STAR experiment. For Au+Au collisions at √sNN = 200 GeV we report v2, for transverse momentum (pT) between 0.2 and 7 GeV/c, using three methods: the event plane method (v2{EP}), two-particle correlations (v2{2}), and four-particle correlations (v2{4}). For Au+Au collisions at √sNN = 62.4 and 39 GeV we report v2{2} for pT \u3c 2 GeV/c. v2{2} and v2{4} are nonzero at low and intermediate pT at 200 GeV, and v2{2} is consistent with zero at low pT at other energies. The v2{2} at the two lower beam energies is systematically lower than at √sNN = 200 GeV for pT \u3c 1GeV/c. This difference may suggest that charm quarks interact less strongly with the surrounding nuclear matter at those two lower energies compared to √sNN = 200 GeV
    • …
    corecore